100 related articles for article (PubMed ID: 19328461)
1. ICBP90 mediates the ERK1/2 signaling to regulate the proliferation of Jurkat T cells.
Fang Z; Xing F; Bronner C; Teng Z; Guo Z
Cell Immunol; 2009; 257(1-2):80-7. PubMed ID: 19328461
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitor of tyrosine phosphorylation AG490 inhibits the proliferation of Jurkat T cells].
Mao CQ; Xing FY; Guo ZF; Fang ZY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar; 26(3):214-7. PubMed ID: 20230682
[TBL] [Abstract][Full Text] [Related]
3. TCR pathway involves ICBP90 gene down-regulation via E2F binding sites.
Abbady AQ; Bronner C; Bathami K; Muller CD; Jeanblanc M; Mathieu E; Klein JP; Candolfi E; Mousli M
Biochem Pharmacol; 2005 Aug; 70(4):570-9. PubMed ID: 15964557
[TBL] [Abstract][Full Text] [Related]
4. Anisomycin suppresses Jurkat T cell growth by the cell cycle-regulating proteins.
Yu C; Xing F; Tang Z; Bronner C; Lu X; Di J; Zeng S; Liu J
Pharmacol Rep; 2013; 65(2):435-44. PubMed ID: 23744428
[TBL] [Abstract][Full Text] [Related]
5. ICBP90 mediates Notch signaling to facilitate human hepatocellular carcinoma growth.
Fu H; Xing F; Lv Y; Zeng B; You P; Liu J
Tissue Cell; 2018 Oct; 54():65-71. PubMed ID: 30309512
[TBL] [Abstract][Full Text] [Related]
6. Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells.
Li Z; Li J; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J
Cell Biol Toxicol; 2008 Oct; 24(5):401-9. PubMed ID: 18224451
[TBL] [Abstract][Full Text] [Related]
7. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
8. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
9. β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
Zhu TZ; Li XM; Luo LH; Xu YH; Cao P; Liu Y; Liang GB
Mol Med Rep; 2014 Aug; 10(2):1122-8. PubMed ID: 24866280
[TBL] [Abstract][Full Text] [Related]
10. The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle.
Jeanblanc M; Mousli M; Hopfner R; Bathami K; Martinet N; Abbady AQ; Siffert JC; Mathieu E; Muller CD; Bronner C
Oncogene; 2005 Nov; 24(49):7337-45. PubMed ID: 16007129
[TBL] [Abstract][Full Text] [Related]
11. Activation of ERK1/2 by protein kinase C-alpha in response to hydrogen peroxide-induced cell death in human gingival fibroblasts.
Gutiérrez-Venegas G; Arreguín-Cano JA; Arroyo-Cruz R; Villeda-Navarro M; Méndez-Mejía JA
Toxicol In Vitro; 2010 Feb; 24(1):319-26. PubMed ID: 19699794
[TBL] [Abstract][Full Text] [Related]
12. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain.
Unoki M; Nishidate T; Nakamura Y
Oncogene; 2004 Oct; 23(46):7601-10. PubMed ID: 15361834
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression.
Trotzier MA; Bronner C; Bathami K; Mathieu E; Abbady AQ; Jeanblanc M; Muller CD; Rochette-Egly C; Mousli M
Biochem Biophys Res Commun; 2004 Jun; 319(2):590-5. PubMed ID: 15178447
[TBL] [Abstract][Full Text] [Related]
14. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells.
Mousli M; Hopfner R; Abbady AQ; Monté D; Jeanblanc M; Oudet P; Louis B; Bronner C
Br J Cancer; 2003 Jul; 89(1):120-7. PubMed ID: 12838312
[TBL] [Abstract][Full Text] [Related]
15. N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.
Chang MC; Wu JY; Liao HF; Chen YJ; Kuo CD
Anticancer Drugs; 2015 Nov; 26(10):1034-42. PubMed ID: 26288134
[TBL] [Abstract][Full Text] [Related]
16. The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation.
Quan ZW; Yang Y; Li JY; Gong W; Qin YY; Li SG
Biomed Pharmacother; 2010 Sep; 64(7):451-7. PubMed ID: 20359855
[TBL] [Abstract][Full Text] [Related]
17. ERK1/2 contributes negative regulation to STAT3 activity in HSS-transfected HepG2 cells.
Tian ZJ; An W
Cell Res; 2004 Apr; 14(2):141-7. PubMed ID: 15115615
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition.
Arima Y; Hirota T; Bronner C; Mousli M; Fujiwara T; Niwa S; Ishikawa H; Saya H
Genes Cells; 2004 Feb; 9(2):131-42. PubMed ID: 15009091
[TBL] [Abstract][Full Text] [Related]
19. cAMP potentiates H(2)O(2)-induced ERK1/2 phosphorylation without the requirement for MEK1/2 phosphorylation.
Lee K; Esselman WJ
Cell Signal; 2001 Sep; 13(9):645-52. PubMed ID: 11495722
[TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinase mediates mevalonate-stimulated human mesangial cell proliferation.
Zhou X; Wang C; Tian J; Wang Y; Li Y; Hu Z; Li R
Mol Med Rep; 2015 Aug; 12(2):2643-9. PubMed ID: 25936991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
